New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)
A new Harris Poll survey commissioned by Alkermes reveals insights into Alcohol Use Disorder (AUD) diagnosis and treatment among 300 adults aged 21-64. The survey highlights that:
47% of respondents were diagnosed following hospital/ER visits, while only 28% were identified through routine screenings. About 79% reported negative feelings upon diagnosis, including fear and shame. Among those treated, 70% are currently in treatment, utilizing various methods including prescription medication (50%), behavioral therapy (46%), and support groups (43%).
The survey found that healthcare providers play a crucial role, with 80% of respondents discussing prescription medications with their providers. Treatment shows positive impacts, with over 50% reporting improvements in physical health (61%), quality of life (60%), and relationships. Notably, 96% of current patients report satisfaction with their treatment.
Despite approximately 28 million U.S. adults having AUD, only about 2 million received treatment in the past year, highlighting a significant treatment gap.
Un nuovo sondaggio Harris Poll commissionato da Alkermes fornisce approfondimenti sulla diagnosi e il trattamento del Disturbo da Uso di Alcol (AUD) tra 300 adulti di età compresa tra 21 e 64 anni. Il sondaggio evidenzia che:
Il 47% dei partecipanti è stato diagnosticato dopo visite in ospedale o al pronto soccorso, mentre solo il 28% è stato identificato tramite screening di routine. Circa il 79% ha riportato sentimenti negativi alla diagnosi, tra cui paura e vergogna. Tra coloro che sono stati trattati, il 70% è attualmente in cura, utilizzando diversi metodi tra cui farmaci prescritti (50%), terapia comportamentale (46%) e gruppi di supporto (43%).
Il sondaggio ha rilevato che i professionisti sanitari svolgono un ruolo fondamentale, con l'80% dei partecipanti che ha discusso di farmaci prescritti con i propri medici. Il trattamento mostra effetti positivi, con oltre il 50% che segnala miglioramenti nella salute fisica (61%), nella qualità della vita (60%) e nelle relazioni. Notevolmente, il 96% dei pazienti attuali è soddisfatto del proprio trattamento.
Nonostante circa 28 milioni di adulti negli Stati Uniti soffrano di AUD, solo circa 2 milioni hanno ricevuto un trattamento nell'ultimo anno, evidenziando un significativo divario nel trattamento.
Una nueva encuesta Harris Poll encargada por Alkermes revela información sobre el diagnóstico y tratamiento del Trastorno por Consumo de Alcohol (AUD) entre 300 adultos de 21 a 64 años. La encuesta destaca que:
El 47% de los encuestados fue diagnosticado tras visitas a hospitales o urgencias, mientras que solo el 28% fue identificado mediante exámenes rutinarios. Alrededor del 79% reportó sentimientos negativos al recibir el diagnóstico, incluyendo miedo y vergüenza. De los tratados, el 70% está actualmente en tratamiento, utilizando diversos métodos como medicamentos recetados (50%), terapia conductual (46%) y grupos de apoyo (43%).
La encuesta encontró que los profesionales de la salud juegan un papel crucial, con el 80% de los encuestados que discutieron sobre medicamentos recetados con sus proveedores. El tratamiento muestra impactos positivos, con más del 50% reportando mejoras en la salud física (61%), calidad de vida (60%) y relaciones. Destaca que el 96% de los pacientes actuales están satisfechos con su tratamiento.
A pesar de que aproximadamente 28 millones de adultos en EE.UU. tienen AUD, solo alrededor de 2 millones recibieron tratamiento el año pasado, evidenciando una brecha significativa en el acceso al tratamiento.
Alkermes가 의뢰한 새로운 Harris Poll 설문조사는 21세에서 64세 사이의 300명의 성인을 대상으로 알코올 사용 장애(AUD) 진단 및 치료에 대한 통찰을 제공합니다. 설문조사 결과는 다음과 같습니다:
응답자의 47%가 병원 또는 응급실 방문 후 진단을 받았으며, 일상적인 선별검사를 통해 진단된 비율은 28%에 불과했습니다. 약 79%는 진단 당시 두려움과 수치심 등 부정적인 감정을 보고했습니다. 치료받은 사람 중 70%는 현재 치료 중이며, 처방 약물(50%), 행동 치료(46%), 지원 그룹(43%) 등 다양한 방법을 이용하고 있습니다.
설문조사는 의료 제공자가 중요한 역할을 한다는 점을 밝혔으며, 응답자의 80%가 의료진과 처방 약물에 대해 논의했습니다. 치료는 신체 건강(61%), 삶의 질(60%), 대인 관계 개선 등 긍정적인 영향을 미치고 있으며, 현재 치료 중인 환자의 96%가 치료에 만족한다고 보고했습니다.
미국 내 약 2,800만 명의 성인이 AUD를 앓고 있지만, 지난 1년간 치료를 받은 사람은 약 200만 명에 불과해 치료 격차가 큰 것으로 나타났습니다.
Une nouvelle enquête Harris Poll commandée par Alkermes révèle des informations sur le diagnostic et le traitement du trouble lié à l'usage d'alcool (AUD) auprès de 300 adultes âgés de 21 à 64 ans. L'enquête met en lumière :
47 % des répondants ont été diagnostiqués après des visites à l'hôpital ou aux urgences, tandis que seulement 28 % ont été identifiés lors de dépistages de routine. Environ 79 % ont ressenti des émotions négatives au moment du diagnostic, notamment peur et honte. Parmi ceux traités, 70 % sont actuellement en cours de traitement, utilisant diverses méthodes telles que les médicaments sur ordonnance (50 %), la thérapie comportementale (46 %) et les groupes de soutien (43 %).
L'enquête a révélé que les professionnels de santé jouent un rôle crucial, 80 % des répondants ayant discuté des médicaments sur ordonnance avec leurs prestataires. Le traitement montre des effets positifs, plus de 50 % rapportant des améliorations de la santé physique (61 %), de la qualité de vie (60 %) et des relations. Notamment, 96 % des patients actuels se déclarent satisfaits de leur traitement.
Bien qu'environ 28 millions d'adultes aux États-Unis souffrent d'AUD, seulement environ 2 millions ont reçu un traitement l'année dernière, mettant en évidence un important déficit de prise en charge.
Eine neue von Alkermes in Auftrag gegebene Harris Poll Umfrage liefert Einblicke in die Diagnose und Behandlung von Alkoholgebrauchsstörung (AUD) bei 300 Erwachsenen im Alter von 21 bis 64 Jahren. Die Umfrage zeigt:
47 % der Befragten wurden nach Krankenhaus- oder Notaufnahmebesuchen diagnostiziert, während nur 28 % durch routinemäßige Screenings identifiziert wurden. Etwa 79 % berichteten bei der Diagnose von negativen Gefühlen wie Angst und Scham. Von den Behandelten befinden sich 70 % derzeit in Behandlung und nutzen verschiedene Methoden, darunter verschreibungspflichtige Medikamente (50 %), Verhaltenstherapie (46 %) und Selbsthilfegruppen (43 %).
Die Umfrage ergab, dass Gesundheitsdienstleister eine entscheidende Rolle spielen, da 80 % der Befragten mit ihren Anbietern über verschreibungspflichtige Medikamente sprechen. Die Behandlung zeigt positive Auswirkungen, wobei über 50 % Verbesserungen der körperlichen Gesundheit (61 %), Lebensqualität (60 %) und Beziehungen berichten. Bemerkenswert ist, dass 96 % der aktuellen Patienten mit ihrer Behandlung zufrieden sind.
Obwohl etwa 28 Millionen Erwachsene in den USA an AUD leiden, haben im vergangenen Jahr nur etwa 2 Millionen eine Behandlung erhalten, was eine erhebliche Versorgungslücke aufzeigt.
- 70% of surveyed AUD patients are currently in active treatment, indicating strong market engagement for Alkermes' AUD products
- 96% satisfaction rate among current AUD treatment patients, suggesting high product efficacy and market retention
- 50% of treated patients use prescription medication, representing significant market opportunity for Alkermes' pharmaceutical solutions
- 80% of respondents discussed prescription medication with healthcare providers, showing strong prescription consideration rates
- Only 2 million out of 28 million adults with AUD received treatment in the past year, indicating significant market penetration challenges
- Low diagnosis rate from routine screenings (28%) suggests barriers to market expansion
- Survey limited to 300 respondents may not fully represent the broader AUD market dynamics
– Survey Respondents Reported That AUD Diagnosis and Decision to Seek Treatment Were Driven by Negative Consequences of Drinking –
– Respondents Cited the Influence of Their Healthcare Providers and the Positive Impact of Treatment on Their Lives –
AUD is a medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational or health consequences. A person living with AUD often needs to drink greater amounts of alcohol to experience its effect and experiences withdrawal symptoms after stopping alcohol use. AUD can affect physical and mental health, and can cause problems with family, friends and work.1 According to the
"Despite increased awareness of AUD, many individuals living with this condition still struggle with stigma and feelings of shame, which can make it challenging to seek help. It's important to understand that AUD is a medical condition—both diagnosable and treatable—with a range of effective treatment options, including medical and psychosocial supports," said Sarah Church, Ph.D., Clinical Psychologist and Founder and Executive Director of Wholeview in
Key findings from the survey include:
- The path to AUD diagnosis is influenced by a number of factors and often prompted by negative mental, physical and psychosocial impacts.
47% of respondents were diagnosed as the result of a hospital or emergency room (ER) visit because they were experiencing AUD symptoms or were involved in an alcohol-related incident, such as driving under the influence (DUI) or a car accident.- For approximately one-third of respondents, diagnosis was driven by factors including: personal concern about alcohol use and desire to discuss with their healthcare provider (
36% ); a visit with a healthcare provider about symptoms that ended up being related to their AUD (35% ); and concerns or encouragement from a loved one to see a healthcare provider (32% ). - A majority (
79% ) of those surveyed responded that they had negative feelings when initially diagnosed, including feeling scared (38% ), ashamed (33% ), concerned (32% ) and embarrassed (32% ).
- Motivations for seeking treatment and types of treatment people engage in vary over the course of a recovery journey, reflecting the individuality of experience and importance of treatment and support options.
83% of those surveyed agreedi with the statement that "it's difficult to treat/manage AUD through willpower alone".- Among those who had ever been treated for AUD, their motivation for seeking treatment included: negative impact of AUD on physical health (
39% ); negative impact of AUD on mental health (38% ); advice from a healthcare provider (36% ); advice/encouragement from family/friends (33% ); and negative impact of AUD on day-to-day life (31% ). - Among those surveyed, many had engaged in treatment:
70% reported currently being treated for AUD;28% reported they have been treated in the past, but are no longer being treated; and2% indicated that they have never been treated for AUD. - Among those who had ever been treated, respondents cited current use of a wide variety of treatment types:
50% were taking prescription medication;46% were participating in behavioral therapy;43% were involved in support group therapy;43% were using alternative treatments;42% were undergoing detox treatment;38% were engaged in outpatient rehabilitation; and32% were engaged in inpatient rehabilitation.
- Healthcare providers play a critical role in diagnosis and helping patients navigate the treatment landscape; however, rates of diagnosis from routine screenings remain low.
- In terms of which healthcare provider diagnosed them,
33% of respondents indicated that they were diagnosed by an addiction specialist and26% by a primary care physician. 80% of all respondents indicated that they had discussed the use of prescription medication to treat their AUD with a healthcare provider and, among those who currently use prescription medication to treat their AUD,50% chose their current medication treatment because their healthcare provider recommended it.- Only
28% of respondents indicated that they were diagnosed as the result of a screening during a standard healthcare visit.
- In terms of which healthcare provider diagnosed them,
- Treatment has a positive impact on respondents' lives and those currently in treatment report motivation to continue on their path.
- Among those who had ever been treated for AUD, over half responded that AUD treatment has had a positiveii impact across various aspects of their life, including physical health (
61% ), overall quality of life (60% ), relationships with [their] children (60% iii), work/career or ability to work (59% iv), mental health (59% ), hobbies/interests (58% ), relationship with friends (57% ), relationship with spouse/partner (57% ), finances (57% ), romantic life (57% ), and social life (55% ). - Among those currently being treated for AUD,
96% were satisfiedv with their current treatment and96% were motivatedvi to adhere to their current treatment.
- Among those who had ever been treated for AUD, over half responded that AUD treatment has had a positiveii impact across various aspects of their life, including physical health (
"According to 2023 data from the National Institute on Alcohol Abuse and Alcoholism, more than 28 million adults in the
i All "agree" percentages represent a sum of the proportion of respondents who selected "somewhat agree" and those who selected "strongly agree" in response to the question asked.
ii All "positive" percentages represent a sum of the proportion of respondents who selected "very positive" and those who selected "somewhat positive" in response to the question asked.
iii Among parents (i.e., adults who are the parent or legal guardian of a child(ren) of any age)
iv Among employed adults (i.e., adults who are full-time, part-time, or self- employed)
v All "satisfied" percentages represent a sum of the proportion of respondents who selected "very satisfied" and those who selected "somewhat satisfied" in response to the question asked.
vi All "motivated" percentages represent a sum of the proportion of respondents who selected "very motivated" and those who selected "somewhat motivated" in response to the question asked.
Survey Methodology
The survey was conducted online in
All sample surveys and polls, whether or not they use probability sampling, are subject to other multiple sources of error which are most often not possible to quantify or estimate, including but not limited to coverage error, error associated with nonresponse, error associated with question wording and response options, and post-survey weighting and adjustments.
For complete survey methodology, including weighting variables and subgroup sample sizes, please contact mediainfo@alkermes.com.
About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
About The Harris Poll
The Harris Poll is a global consulting and market research firm that strives to reveal the authentic values of modern society to inspire leaders to create a better tomorrow. It works with clients in three primary areas: building twenty-first-century corporate reputation, crafting brand strategy and performance tracking, and earning organic media through public relations research. One of the longest running surveys in the
References:
1 National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol's Effects on Health: Understanding Alcohol Use Disorder. Updated September 2024. Accessed April 2025. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-alcohol-use-disorder
2 National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol's Effects on Health: Alcohol Use Disorder (AUD) in
3 National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol's Effects on Health: Alcohol Treatment in
Alkermes Contacts:
For Investors: Sandy Coombs, +1 781 609 6377
For Media: Marisa Borgasano, +1 781 609 6659
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-survey-provides-insights-into-diagnosis-and-treatment-journey-for-people-living-with-alcohol-use-disorder-aud-302441991.html
SOURCE Alkermes plc